These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35453581)

  • 1. Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment.
    Mueller AL; Brockmueller A; Fahimi N; Ghotbi T; Hashemi S; Sadri S; Khorshidi N; Kunnumakkara AB; Shakibaei M
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer treatment using bacteria: focus on molecular mechanisms.
    Ebrahimzadeh S; Ahangari H; Soleimanian A; Hosseini K; Ebrahimi V; Ghasemnejad T; Soofiyani SR; Tarhriz V; Eyvazi S
    BMC Microbiol; 2021 Jul; 21(1):218. PubMed ID: 34281519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriotherapy in gastrointestinal cancer.
    Soleimanpour S; Hasanian SM; Avan A; Yaghoubi A; Khazaei M
    Life Sci; 2020 Aug; 254():117754. PubMed ID: 32389833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bacterial instrument as a promising therapy for colon cancer.
    Yaghoubi A; Khazaei M; Avan A; Hasanian SM; Soleimanpour S
    Int J Colorectal Dis; 2020 Apr; 35(4):595-606. PubMed ID: 32130489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriotherapy in Breast Cancer.
    Yaghoubi A; Khazaei M; Hasanian SM; Avan A; Cho WC; Soleimanpour S
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteria as a double-action sword in cancer.
    Yaghoubi A; Khazaei M; Jalili S; Hasanian SM; Avan A; Soleimanpour S; Cho WC
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188388. PubMed ID: 32589907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the treatment of colorectal cancer caused by gut microbiota.
    de Souza JB; Brelaz-de-Castro MCA; Cavalcanti IMF
    Life Sci; 2022 Feb; 290():120202. PubMed ID: 34896161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia.
    Kohoutova D; Smajs D; Moravkova P; Cyrany J; Moravkova M; Forstlova M; Cihak M; Rejchrt S; Bures J
    BMC Infect Dis; 2014 Dec; 14():733. PubMed ID: 25540872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites.
    Han S; Zhuang J; Wu Y; Wu W; Yang X
    Cancer Manag Res; 2020; 12():8703-8720. PubMed ID: 33061569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gut microbiota in the colorectal cancer and potential target therapy.
    Li J; Zhu Y; Yang L; Wang Z
    Discov Oncol; 2022 Jun; 13(1):51. PubMed ID: 35749000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview on upper respiratory tract infections and bacteriotherapy as innovative therapeutic strategy.
    Bellussi LM; Passali FM; Ralli M; De Vincentiis M; Greco A; Passali D
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(1 Suppl):27-38. PubMed ID: 30920638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved.
    Afrin S; Giampieri F; Gasparrini M; Forbes-Hernández TY; Cianciosi D; Reboredo-Rodriguez P; Zhang J; Manna PP; Daglia M; Atanasov AG; Battino M
    Biotechnol Adv; 2020; 38():107322. PubMed ID: 30476540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basics to advances in nanotherapy of colorectal cancer.
    Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
    Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
    Fan X; Jin Y; Chen G; Ma X; Zhang L
    Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang Z; Ji G
    Oncol Lett; 2019 Aug; 18(2):975-982. PubMed ID: 31423156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota.
    Pan S; Guo Y; Hong F; Xu P; Zhai Y
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166281. PubMed ID: 34610472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.